Baxter International told investors at the JP Morgan Healthcare Conference today that more changes are on the table, including divestitures, small acquisitions and assessments of product offerings ...

7.52% or $320 upside for small Investors in base case ... have a look at the following sensitivity table. If the performance of Baxalta relative to Baxter is not more than 20% worse, the trade ...